gusperimus and sphingosine
gusperimus has been researched along with sphingosine in 4 studies
Research
Studies (4)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Fujiwara, I; Matsuda, T; Mizuta, N; Nakajima, H; Oka, T; Yamagishi, H | 1 |
Diaz-Romero, J; Vogt, G; Weckbecker, G | 1 |
Dumont, FJ | 1 |
Emre, S; Krieger, NR | 1 |
Reviews
2 review(s) available for gusperimus and sphingosine
Article | Year |
---|---|
Treatment of transplant rejection: are the traditional immunosuppressants good enough?
Topics: Antibodies, Monoclonal; Antimetabolites; Calcineurin Inhibitors; Cyclosporine; Cytokines; Drug Design; Fingolimod Hydrochloride; Graft Rejection; Guanidines; Humans; Immunosuppressive Agents; Lymphocyte Activation; Molecular Structure; Organ Transplantation; Propylene Glycols; Signal Transduction; Sirolimus; Sphingosine; T-Lymphocytes; Tacrolimus; Triterpenes | 2001 |
Novel immunosuppressants.
Topics: Abatacept; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; CD40 Ligand; Child; Fingolimod Hydrochloride; Guanidines; Humans; Immunoconjugates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Depletion; Propylene Glycols; Sphingosine; T-Lymphocytes | 2004 |
Other Studies
2 other study(ies) available for gusperimus and sphingosine
Article | Year |
---|---|
Prolongation of concordant xenograft survival by a newly developed drug, FTY720.
Topics: Animals; Antibodies, Heterophile; Combined Modality Therapy; Cricetinae; Fingolimod Hydrochloride; Graft Survival; Guanidines; Heart Transplantation; Immunosuppression Therapy; Immunosuppressive Agents; Lymphocyte Culture Test, Mixed; Propylene Glycols; Rats; Rats, Inbred Lew; Sphingosine; Spleen; Splenectomy; Transplantation, Heterologous | 1999 |
Coexpression of CD4 and CD8alpha on rat T-cells in whole blood: a sensitive marker for monitoring T-cell immunosuppressive drugs.
Topics: Animals; Biomarkers; CD4 Antigens; CD4-Positive T-Lymphocytes; CD8 Antigens; Concanavalin A; Cyclosporine; Everolimus; Fingolimod Hydrochloride; Flow Cytometry; Guanidines; Immunosuppressive Agents; Mitogens; Propylene Glycols; Rats; Rats, Inbred Lew; Sirolimus; Sphingosine; Tacrolimus | 2001 |